Fabrice Garrido

Title: **Fabrice Garrido: Innovator in Central Nervous System Therapies**

Introduction

Fabrice Garrido, an accomplished inventor based in Illkirch, France, has made significant strides in the field of neuroscience through his innovative patents. With a total of three patents to his name, he is focused on developing compounds that could dramatically improve treatments for various central nervous system disorders.

Latest Patents

Garrido's most recent patent involves "Spiropiperidine allosteric modulators of nicotinic acetylcholine receptors." This innovative disclosure pertains to compounds that are useful as modulators of the α7 nAChR, with applications aimed at preventing, treating, or ameliorating diseases such as cognitive impairments associated with Alzheimer's disease, Parkinson's disease, and schizophrenia. It also addresses conditions like L-DOPA induced-dyskinesia and inflammation.

Another noteworthy patent by Garrido is titled "Substituted-N-heteroaryl compounds and uses thereof," which introduces activators of Kv3.1 and/or Kv3.2 channels. These compounds hold therapeutic potential for treating cognitive dysfunction and the negative symptoms linked to central nervous system disorders, including schizophrenia, Alzheimer's disease, Tourette's syndrome, autism, dementia, epilepsy, and other conditions characterized by dysfunctional gamma oscillations.

Career Highlights

Fabrice Garrido has built a robust career by collaborating with esteemed companies in the pharmaceutical sector. He has worked with Bionomics Inc. and Merck Sharp & Dohme Corporation, where he contributed to groundbreaking research and development efforts that align with his innovative patents.

Collaborations

Throughout his career, Garrido has collaborated with notable colleagues such as Hamish Toop and Rajinder Singh. These partnerships have been instrumental in advancing his research and bringing his innovative ideas to fruition.

Conclusion

Fabrice Garrido stands at the forefront of innovation in the treatment of central nervous system disorders. With a strong focus on developing unique compounds through his patents, he continues to contribute valuable research that may lead to significant breakthroughs in the medical field. His work not only showcases the importance of innovation in medicine but also highlights the potential for improved therapeutic strategies for patients dealing with complex neurological conditions.